Carlyle Group’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $642K | Hold |
269,895
| – | – | 0.01% | 18 |
|
|
2025
Q1 | $1.16M | Hold |
269,895
| – | – | 0.03% | 19 |
|
|
2024
Q4 | $2.33M | Sell |
269,895
-1
| -0% | -$9 | 0.06% | 19 |
|
|
2024
Q3 | $4.53M | Hold |
269,896
| – | – | 0.48% | 12 |
|
|
2024
Q2 | $4.16M | Hold |
269,896
| – | – | 0.39% | 15 |
|
|
2024
Q1 | $4.45M | Hold |
269,896
| – | – | 0.28% | 17 |
|
|
2023
Q4 | $4.32M | Hold |
269,896
| – | – | 0.21% | 16 |
|
|
2023
Q3 | $20.5M | Hold |
269,896
| – | – | 0.89% | 11 |
|
|
2023
Q2 | $17.7M | Buy |
269,896
+62,500
| +30% | +$4.09M | 0.63% | 11 |
|
|
2023
Q1 | $12.2M | Buy |
+207,396
| New | +$12.2M | 0.37% | 14 |
|